Targeting the epidermal growth factor receptor in the treatment of colorectal cancer : State of the artDIASIO, Robert B; FOURIE, Jeanne.Drugs (Basel). 2006, Vol 66, Num 11, pp 1441-1463, issn 0012-6667, 23 p.Article

Histone Deacetylase Inhibitors: Current Status and Overview of Recent Clinical TrialsXUJUN MA; EZZELDIN, Hany H; DIASIO, Robert B et al.Drugs (Basel). 2009, Vol 69, Num 14, pp 1911-1934, issn 0012-6667, 24 p.Article

Perspectives in the treatment of colorectal cancerOZER, Howard; DIASIO, Robert B.Seminars in oncology. 2004, Vol 31, Num 6, pp 14-18, issn 0093-7754, 5 p., SUP15Article

Genetic testing in cancer therapeuticsEZZELDIN, Hany H; DIASIO, Robert B.Clinical cancer research. 2006, Vol 12, Num 14, pp 4137-4141, issn 1078-0432, 5 p., 1Article

Profound dihydropyrimidine dehydrogenase deficiency resulting from a novel compound heterozygote genotypeJOHNSON, Martin R; KANGSHENG WANG; DIASIO, Robert B et al.Clinical cancer research. 2002, Vol 8, Num 3, pp 768-774, issn 1078-0432Article

A comparative analysis of translated dihydropyrimidine dehydrogenase cDNA; conservation of functional domains and relevance to genetic polymorphismsMATTISON, Lori K; JOHNSON, Martin R; DIASIO, Robert B et al.Pharmacogenetics (London). 2002, Vol 12, Num 2, pp 133-144, issn 0960-314XArticle

Prognostic Impact of Body Mass Index Stratified by Smoking Status in Patients With Esophageal AdenocarcinomaYOON, Harry H; LEWIS, Mark A; QIAN SHI et al.Journal of clinical oncology. 2011, Vol 29, Num 34, pp 4561-4567, issn 0732-183X, 7 p.Article

Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer : Expression analysis of genes related to outcomeWASIF SAIF, M; ELOUBEIDI, Mohammaed A; RUSSO, Suzanne et al.Journal of clinical oncology. 2005, Vol 23, Num 34, pp 8679-8687, issn 0732-183X, 9 p.Conference Paper

Phenotypic Profiling of DPYD Variations Relevant to 5-Fluorouracil Sensitivity Using Real-time Cellular Analysis and In Vitro Measurement of Enzyme ActivityOFFER, Steven M; WEGNER, Natalie J; FOSSUM, Croix et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 6, pp 1958-1968, issn 0008-5472, 11 p.Article

Dihydropyrimidine dehydrogenase deficiency in an Indian populationMUHAMMAD WASIF SAIF; MATTISON, Lori; CAROLLO, Tom et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 3, pp 396-401, issn 0344-5704, 6 p.Article

Capecitabine induces rapid, sustained response in two patients with extensive Oral verrucous carcinomaSALESIOTIS, Anastasios; SOONG, Richie; DIASIO, Robert B et al.Clinical cancer research. 2003, Vol 9, Num 2, pp 580-585, issn 1078-0432, 6 p.Article

DPYD*2A mutation : the most common mutation associated with DPD deficiencySAIF, M. W; EZZELDIN, Hany; VANCE, Katisha et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 4, pp 503-507, issn 0344-5704, 5 p.Article

Increased prevalence of dihydropyrimidine dehydrogenase deficiency in african-americans compared with caucasiansMATTISON, Lori Kay; FOURIE, Jeanne; DESMOND, Renee A et al.Clinical cancer research. 2006, Vol 12, Num 18, pp 5491-5495, issn 1078-0432, 5 p.Article

Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM)GRUNDA, Jessica M; BURTON NABORS, L; WENQUAN WANG et al.Journal of neuro-oncology. 2006, Vol 80, Num 3, pp 261-274, issn 0167-594X, 14 p.Article

Methylation of the DPYD promoter : An alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patientsEZZELDIN, Hany H; LEE, Adam M; MATTISON, Lori K et al.Clinical cancer research. 2005, Vol 11, Num 24, pp 8699-8705, issn 1078-0432, 7 p., 1Article

Association of HER2/ErbB2 Expression and Gene Amplification with Pathologic Features and Prognosis in Esophageal AdenocarcinomasYOON, Harry H; QIAN SHI; SINICROPE, Frank A et al.Clinical cancer research (Print). 2012, Vol 18, Num 2, pp 546-554, issn 1078-0432, 9 p.Article

Common Breast Cancer Susceptibility Loci Are Associated with Triple-Negative Breast CancerSTEVENS, Kristen N; VACHON, Celine M; GODWIN, Andrew K et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 19, pp 6240-6249, issn 0008-5472, 10 p.Article

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor―negative breast cancerHAIMAN, Christopher A; CHEN, Gary K; BAGLIETTO, Laura et al.Nature genetics. 2011, Vol 43, Num 12, pp 1210-1214, issn 1061-4036, 5 p.Article

Role of matrix metalloproteinases in colorectal carcinogenesisHESLIN, Martin J; JIEMING YAN; JOHNSON, Martin R et al.Annals of surgery. 2001, Vol 233, Num 6, pp 786-792, issn 0003-4932Conference Paper

DPYD Variants as Predictors of 5-fluorouracil Toxicity in Adjuvant Colon CancerTreatment (NCCTG NO147)LEE, Adam M; QIAN SHI; PAVEY, Emily et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 12, issn 0027-8874, 296.1-296.12Article

A phase II study of modulated-capecitabine and docetaxel in chemonaive patients with advanced non-small cell lung cancer (NSCLC)BERTINO, Erin M; BEKAII-SAAB, Tanios; FERNANDEZ, Soledad et al.Lung cancer. 2013, Vol 79, Num 1, pp 27-32, issn 0169-5002, 6 p.Article

Rapid identification of Dihydropyrimidine dehydrogenase deficiency by using a novel 2-¹³C-uracil breath testMATTISON, Lori K; EZZELDIN, Hany; CARPENTER, Mark et al.Clinical cancer research. 2004, Vol 10, Num 8, pp 2652-2658, issn 1078-0432, 7 p.Article

Comparative Functional Analysis of DPYD Variants of Potential Clinical Relevance to Dihydropyrimidine Dehydrogenase ActivityOFFER, Steven M; FOSSUM, Croix C; WEGNER, Natalie J et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 9, pp 2545-2554, issn 0008-5472, 10 p.Article

Genetic regulation of ss-ureidopropionase and its possible implication in altered uracil catabolismTHOMAS, Holly R; EZZELDIN, Hany H; GUARCELLO, Vincenzo et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 1, pp 25-35, issn 1744-6872, 11 p.Article

The uracil breath test in the assessment of dihydropyrimidine dehydrogenase activity : Pharmacokinetic relationship between expired ¹³CO₂ and plasma [2-¹³C]dihydrouracilMATTISON, Lori K; FOURIE, Jeanne; HIRAO, Yukihiro et al.Clinical cancer research. 2006, Vol 12, Num 2, pp 549-555, issn 1078-0432, 7 p.Article